A histamine-independent itch pathway is required for allergic ocular itch

J Allergy Clin Immunol. 2016 Apr;137(4):1267-1270.e6. doi: 10.1016/j.jaci.2015.08.047. Epub 2015 Oct 28.

Abstract

Non-histaminergic TRPA1 neural pathway is required for the development of allergic ocular itch. Pharmacological inhibition of TRPA1 channel can lead to novel therapeutic strategies to treat ocular itch in severe allergic conjunctivitis.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Conjunctivitis, Allergic / complications
  • Conjunctivitis, Allergic / immunology*
  • Histamine / metabolism*
  • Mice
  • Mice, Knockout
  • Pruritus / immunology*
  • TRPA1 Cation Channel
  • TRPV Cation Channels / deficiency
  • TRPV Cation Channels / immunology*
  • Transient Receptor Potential Channels / deficiency
  • Transient Receptor Potential Channels / immunology*

Substances

  • Biomarkers
  • TRPA1 Cation Channel
  • TRPV Cation Channels
  • TRPV1 protein, mouse
  • Transient Receptor Potential Channels
  • Trpa1 protein, mouse
  • Histamine